Literature DB >> 30021354

Sirt3-mediated mitochondrial fission regulates the colorectal cancer stress response by modulating the Akt/PTEN signalling pathway.

Yan Wang1, Xiaohui Sun1, Kaihua Ji1, Liqing Du2, Chang Xu1, Ningning He1, Jinhan Wang1, Yang Liu1, Qiang Liu3.   

Abstract

Sirtuin-3 (Sirt3), a sub-family member of the nicotinamide adenine dinucleotide-dependent histone deacetylases, has been reported to be involved in mitochondrial oxidative stress regulation, mitochondrial calcium management, mitophagy activation, and mitochondrial energy metabolism. The aim of our study was to explore the functional role of Sirt3 in colorectal cancer stress, focusing particularly on its effects on mitochondrial fission. Our study demonstrated that Sirt3 was highly upregulated in colorectal cancer cells compared to normal rectal mucosa cells. However, the genetic ablation of Sirt3 reduced colorectal cancer cell viability, mobility and proliferation. At the molecular level, we found that Sirt3 knockdown suppressed the expression of adhesive factors and cyclins. Furthermore, Sirt3 deletion was also associated with mitochondrial membrane potential reduction, ROS overproduction, mPTP opening, mitochondrial pro-apoptotic upregulation, and caspase-9-related death programme activation. Furthermore, we determined that Sirt3 regulated the colorectal cancer stress response by modulating mitochondrial fission. The loss of Sirt3 triggered fatal mitochondrial fission by suppressing the Akt/PTEN pathway. Re-activation of the Akt/PTEN pathway combatted mitochondrial fission and promoted colorectal cancer mobility, survival, and growth. Altogether, these findings provide an additional rationale for the function of Sirt3 in supporting the growth and survival of colorectal cancer.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Akt/PTEN pathway; Apoptosis; Colorectal cancer; Migration; Sirt3

Mesh:

Substances:

Year:  2018        PMID: 30021354     DOI: 10.1016/j.biopha.2018.06.071

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  8 in total

1.  Sirtuin 3 inhibition induces mitochondrial stress in tongue cancer by targeting mitochondrial fission and the JNK-Fis1 biological axis.

Authors:  Jichi Zhou; Menghan Shi; Man Li; Long Cheng; Jinsuo Yang; Xin Huang
Journal:  Cell Stress Chaperones       Date:  2019-01-17       Impact factor: 3.667

Review 2.  Association of sirtuins (SIRT1-7) with lung and intestinal diseases.

Authors:  Yuhan Chen; Di Zhou; Yuan Feng; Bingxin Li; Yong Cui; Gang Chen; Ning Li
Journal:  Mol Cell Biochem       Date:  2022-05-20       Impact factor: 3.396

Review 3.  The Double-Edged Sword of SIRT3 in Cancer and Its Therapeutic Applications.

Authors:  Shumin Ouyang; Qiyi Zhang; Linlin Lou; Kai Zhu; Zeyu Li; Peiqing Liu; Xiaolei Zhang
Journal:  Front Pharmacol       Date:  2022-04-27       Impact factor: 5.988

4.  Sirt3 Regulates Response to Oxidative Stress by Interacting with BER Proteins in Colorectal Cancer.

Authors:  J Kabzinski; A Walczak; I Majsterek
Journal:  Genet Res (Camb)       Date:  2022-04-07       Impact factor: 1.375

5.  Hypoxic Training Ameliorates Skeletal Muscle Microcirculation Vascular Function in a Sirt3-Dependent Manner.

Authors:  Chunwei Ma; Yongcai Zhao; Xiaoqing Ding; Binghong Gao
Journal:  Front Physiol       Date:  2022-07-18       Impact factor: 4.755

Review 6.  Mitochondrial sirtuin 3 and various cell death modalities.

Authors:  Maria A Yapryntseva; Polina V Maximchik; Boris Zhivotovsky; Vladimir Gogvadze
Journal:  Front Cell Dev Biol       Date:  2022-07-22

7.  Levosimendan Protects against Doxorubicin-Induced Cardiotoxicity by Regulating the PTEN/Akt Pathway.

Authors:  Ling-Li Li; Li Wei; Ning Zhang; Wen-Ying Wei; Can Hu; Wei Deng; Qi-Zhu Tang
Journal:  Biomed Res Int       Date:  2020-06-07       Impact factor: 3.246

Review 8.  Mammalian AKT, the Emerging Roles on Mitochondrial Function in Diseases.

Authors:  Xiaoxian Xie; Ruonan Shu; Chunan Yu; Zhengwei Fu; Zezhi Li
Journal:  Aging Dis       Date:  2022-02-01       Impact factor: 6.745

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.